Cargando…
Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice
Idiopathic pulmonary fibrosis (IPF) is a progressive and usually fatal lung disease that is characterized by fibroblast proliferation and extracellular matrix remodeling, which result in irreversible distortion of the lung’s architecture and the formation of focal fibrous hyperplasia. The molecular...
Autores principales: | Li, Xiaohe, Bi, Zhun, Liu, Shuaishuai, Gao, Shaoyan, Cui, Yunyao, Huang, Kai, Huang, Mengying, Mao, Jiahe, Li, Lixin, Gao, Jingjing, Sun, Tao, Zhou, Honggang, Yang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753632/ https://www.ncbi.nlm.nih.gov/pubmed/31572194 http://dx.doi.org/10.3389/fphar.2019.01021 |
Ejemplares similares
-
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
por: Miao, Yang, et al.
Publicado: (2023) -
Antifibrotic Mechanism of Piceatannol in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Sheng, Hanjing, et al.
Publicado: (2022) -
Protective Effect of Remdesivir Against Pulmonary Fibrosis in Mice
por: Li, Xiaohe, et al.
Publicado: (2021) -
Imrecoxib attenuates bleomycin-induced pulmonary fibrosis in mice
por: Miao, Yang, et al.
Publicado: (2023) -
Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting Wnt Signaling Pathway
por: Li, Xiaohe, et al.
Publicado: (2021)